CNS and Neurological Disorders - Drug Targets : Impact Factor & More
eISSN: 1996-3181pISSN: 1871-5273
Share this on:
Key Metrics
CiteScore 
6.4
Impact Factor
< 5
SNIP
0.64
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
CNS and Neurological Disorders - Drug Targets Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in CNS and Neurological Disorders - Drug Targets ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in CNS and Neurological Disorders - Drug Targets
Endothelial-to-mesenchymal Transition at the Blood-brain Barrier: Molecular Mechanisms and Pathological Roles Across Brain Diseases.
- 25 Jul 2026
- CNS & neurological disorders drug targets
Zolpidem vs. Emerging Hypnotics: Neuropsychiatric Effects and Ethical Considerations.
- 16 Jul 2026
- CNS & neurological disorders drug targets
Exosomes in Neurodegenerative Disorders: Isolation Strategies, Therapeutic Potential, and Clinical Trials.
- 14 Jul 2026
- CNS & neurological disorders drug targets
MiR-206-mediated Regulation in Depression: From Pathophysiological Mechanisms to Intranasal AntagomiR-206 Therapy.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Syntaxin-4 at the Crossroads of Synaptic Plasticity and Neurodegeneration: From Molecular Mechanisms to Biomarker and Therapeutic Potential.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Characteristics of Dysphagia Secondary to Ultrasound-guided Botulinum Injections for Cervical Dystonia.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Endothelial-to-mesenchymal Transition at the Blood-brain Barrier: Molecular Mechanisms and Pathological Roles Across Brain Diseases.
- 25 Jul 2026
- CNS & neurological disorders drug targets
Zolpidem vs. Emerging Hypnotics: Neuropsychiatric Effects and Ethical Considerations.
- 16 Jul 2026
- CNS & neurological disorders drug targets
Exosomes in Neurodegenerative Disorders: Isolation Strategies, Therapeutic Potential, and Clinical Trials.
- 14 Jul 2026
- CNS & neurological disorders drug targets
MiR-206-mediated Regulation in Depression: From Pathophysiological Mechanisms to Intranasal AntagomiR-206 Therapy.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Syntaxin-4 at the Crossroads of Synaptic Plasticity and Neurodegeneration: From Molecular Mechanisms to Biomarker and Therapeutic Potential.
- 8 Jul 2026
- CNS & neurological disorders drug targets
Characteristics of Dysphagia Secondary to Ultrasound-guided Botulinum Injections for Cervical Dystonia.
- 8 Jul 2026
- CNS & neurological disorders drug targets
FAQs on CNS and Neurological Disorders - Drug Targets
How long has CNS and Neurological Disorders - Drug Targets been actively publishing? 
What is the publishing frequency of CNS and Neurological Disorders - Drug Targets?
How many articles did CNS and Neurological Disorders - Drug Targets publish last year?
What is the eISSN & pISSN for CNS and Neurological Disorders - Drug Targets?
What is Citescore for CNS and Neurological Disorders - Drug Targets?
What is SNIP score for CNS and Neurological Disorders - Drug Targets?
Who is the publisher of CNS and Neurological Disorders - Drug Targets?
